The New England Journal of Medicine

October 15, 2015

Cancer Researcher Published in New England Journal of Medicine

David Robinson

LITTLE ROCK – Identifying a patient’s genetic mutation led University of Arkansas for Medical Sciences (UAMS) physician-researcher Ling Gao, M.D., Ph.D., to an existing drug that eliminated the patient’s stage IV Merkel-cell carcinoma. Gao’s findings, made in collaboration with two other UAMS researchers, were published today in The New England Journal of Medicine. Metastatic Merkel-cell…